KROS
Keros Therapeutics IncHenter pris…
Værdiansættelse (TTM)
Kursudvikling
Kun 80 handelsdage i databasen. Viser al tilgængelig historik.
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 0,3 år
- Pris-dage
- 80
- Årsregnskaber
- 8
- Peers
- 0/0
- Valuation
- 4/6
- Fundamentals
- 6/8
- Datovindue
- 2026-02-09 til 2026-06-03
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Mangler ca. 9,7 års prishistorik før ideal/full.
- Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
- Kør compute-multiples for manglende valuation metrics.
- Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.
Seneste assessment
KROS vurderet 2026-06-10
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: Own P/E 1.3 vs peer median 12.6; cheaper than peers if business quality is comparable.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 15.6.2026 | BIENAIME JEAN JACQUES | — | ▲ KØB | 1.000 | 10.190 USD | sec |
| 11.6.2026 | Newton Charles W. | — | ▼ SALG | -550 | -5.522 USD | sec |
| 4.6.2026 | Seth Alpna | — | ▼ SALG | -2.625 | -28.140 USD | sec |
| 4.6.2026 | Farzan Nima | — | ▼ SALG | -2.625 | -28.166 USD | sec |
| 4.6.2026 | Knowles Julius | — | ▼ SALG | -2.625 | -28.166 USD | sec |
| 3.6.2026 | Farzan Nima | — | · ANDET | 7.142 | — | sec |
| 3.6.2026 | BIENAIME JEAN JACQUES | — | · ANDET | 7.142 | — | sec |
| 3.6.2026 | GRAY MARY ANN | — | · ANDET | 7.142 | — | sec |
| 3.6.2026 | Seth Alpna | — | · ANDET | 7.142 | — | sec |
| 3.6.2026 | Knowles Julius | — | · ANDET | 7.142 | — | sec |
| 15.5.2026 | BIENAIME JEAN JACQUES | — | ▲ KØB | 1.000 | 10.580 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | -1,21 | -0,92 | -31.5% | -31.5% | Miss |
| 2025Q4 | 30.1.2026 | -0,86 | -0,45 | -90.4% | -90.4% | Miss |
| 2025Q3 | 30.10.2025 | -0,18 | -0,92 | +80.5% | +80.5% | Beat |
| 2025Q2 | 30.7.2025 | -0,76 | -1,13 | +32.5% | +32.5% | Beat |